The numbers associated with the No Surprises Act (NSA) are no longer shocking—they are, by every metric, prohibitively expensive. What was envisioned by federal lawmakers as a patient-protection measure to eliminate the scourge of balance billing has, in practice, morphed into a high-stakes financial arena where health plans are consistently outmaneuvered.
According to joint data from the Departments of Labor, Treasury, and Health and Human Services (HHS), healthcare providers currently prevail in 88% of Independent Dispute Resolution (IDR) cases. When they win, the financial damage to payers is significant; analyses of Centers for Medicare & Medicaid Services (CMS) data indicate that median awards hover at approximately 450% of comparable in-network rates. The cumulative impact is staggering: in the first three years of the program, excess costs to the U.S. healthcare system surpassed $5 billion. Perhaps most alarming is the administrative burden, with fees reaching $844 million in the first half of 2025 alone—a figure that nearly matches the total administrative spend from 2022 through 2024 combined.
For health plan CFOs and CEOs, these are not mere market abstractions. They represent direct, trackable budget exposure. Every arbitration loss constitutes a payment made well above a defensible in-network rate, directly inflating medical loss ratios (MLR), pressuring premiums, and compounding quietly across the entirety of a payer’s book of business.
A Chronology of Escalation: From Policy to Profit Model
When Congress drafted the No Surprises Act, federal officials projected a manageable volume of approximately 17,000 IDR disputes per year. The reality has been nothing short of a systemic deluge. By the end of 2025, the actual number of disputes had soared to 4.8 million—nearly 280 times the original federal estimate.
The trajectory of these disputes shows no signs of flattening. In the first half of 2025, the volume of dispute submissions more than doubled compared to the same period in 2024. For regional and mid-sized health plans, this is not a background concern; it is an existential operational threat. Most payer organizations were not designed to absorb this volume, and the administrative infrastructure required to manage such a deluge is expanding at a rate that is rapidly outpacing original budget forecasts.
This is not a compliance hurdle that will resolve itself through the refinement of internal processes. The current environment has created a feedback loop where provider organizations—particularly those with sophisticated legal and arbitration infrastructure—have effectively weaponized the IDR system. For many large provider groups, filing for IDR is no longer a “last resort” to resolve a disagreement; it has evolved into a highly profitable, scalable business model.
The Misplaced Focus: Why Arbitration is the Wrong Battlefield
The industry response to this crisis has been largely uniform: health plans have poured capital into dispute management, investing in sophisticated tracking systems, external legal support, and rigorous arbitration preparation. While these investments are logical if one assumes the battle must be won at the arbitration table, the data suggests otherwise. The critical fight is not occurring in front of an arbitrator; it is happening in the 30 days preceding the filing.
The No Surprises Act mandates a 30-day "open negotiation" period before either party can initiate the formal IDR process. Legislators designed this window to serve as the primary dispute resolution mechanism—a space where clinical and financial disagreements could be settled through good-faith negotiation.
Today, this mechanism is largely broken. Providers who have mastered the high-volume IDR game have learned that skipping meaningful negotiation and proceeding straight to arbitration yields superior financial returns. Because the current arbitration environment frequently results in awards at 450% of in-network rates, the incentive for providers to settle for a reasonable, defensible rate is nonexistent. Consequently, the 30-day window expires, the IDR filing is submitted, and the health plan is forced onto the provider’s timeline, absorbing filing fees, legal costs, and the eventual impact of an arbitration loss.
The Anatomy of a Better Strategy: Active vs. Passive Management
The divide between winning and losing often comes down to how a health plan treats that 30-day window.
The Passive Approach: A dispute is logged, standardized automated communications are sent to the provider, and the clock is allowed to run. By day 31, the case is filed, and the plan enters a reactive, costly arbitration phase. This is the path of least resistance, and it is precisely what high-volume, opportunistic providers are counting on.
The Active Approach: The moment a dispute arises, an experienced negotiator engages the provider directly. This is not a portal-based interaction or a generic email template. It is a substantive, human-to-human conversation aimed at reaching a mutually acceptable figure before the window closes.
The operational difference is subtle, but the outcome difference is seismic. Owning the process is not the same as winning the dispute. Many vendors specialize in efficiently managing thousands of IDR filings, but if those filings result in an 88% provider win rate, the process is "running smoothly" only for the provider. The plan, meanwhile, is losing money quietly and consistently.
Redefining Possibility: The AMPS Model
AMPS is fundamentally redefining the approach to the No Surprises Act for health plans, TPAs, and the brokers who advise self-funded employers. Through its solution, PriceDynamix, AMPS operates at the intersection of strategic claim repricing, network integrity, and expert-led negotiation.
Rather than building an approach centered solely on compliance, AMPS has developed an integrated strategy that treats the 30-day negotiation window as the primary theater of operations.
1. Defensible Pricing from the Start
A plan’s ability to defend a payment is often determined before the dispute even reaches the desk of a negotiator. If a payment methodology is opaque, inconsistent, or lacks a clear, defensible logic, the provider holds all the leverage. AMPS builds defensibility into the pricing methodology from the beginning, ensuring that when a dispute arises, the health plan is not scrambling to provide an explanation, but is instead delivering a rigorous, data-backed justification.
2. Immediate, Proactive Negotiation
The moment a dispute surfaces, AMPS negotiators take control. By engaging directly with the provider, AMPS cuts through the administrative noise. Because these negotiators understand the legal framework of the NSA and the real-world realities of provider behavior, they are able to resolve a significant portion of disputes before they ever reach the status of an IDR filing.
For the provider, the experience shifts from dealing with a passive, automated system to engaging with a prepared, active counterparty. When providers realize that a plan is not a "soft target" and that a fair, negotiated resolution is the best possible outcome, the trajectory changes. Fewer filings mean lower administrative costs, fewer arbitration fees, and a dramatic reduction in the financial leakage that has plagued the industry for the last three years.
Implications for the Future of Healthcare Finance
The 88% provider win rate in IDR is not an immutable law of the healthcare market; it is a temporary symptom of a system that has been allowed to operate without meaningful friction. It is the result of vendors treating the open negotiation window as a bureaucratic formality and health plans failing to adopt a proactive, resolution-first strategy.
The math on IDR is not fixed. The current trends—the massive surge in filings, the rising costs of administration, and the erosion of plan assets—are the results of choices made by organizations regarding how they manage their exposure.
For health plan leaders, the mandate is clear: the era of passive compliance is over. Those who continue to treat the 30-day window as a mere procedural step will continue to see their medical loss ratios suffer. Conversely, plans that prioritize defensible pricing and active, expert-led negotiation are finding that they can reclaim control.
The goal is not simply to "manage" the No Surprises Act, but to master it. By shifting the focus from the arbitration table back to the negotiation window, health plans can protect their dollars at the source, rather than attempting to recover them after the fact.
For organizations ready to pivot from reactive defense to strategic resolution, the opportunity is significant. It is time to stop absorbing the costs of an inefficient system and start leveraging a strategy that brings accountability back to the claims process.
To learn more about how your organization can reduce its IDR exposure and implement a negotiation-first strategy, visit the AMPS team at https://www.amps.com/strategy.
